decisionhealth Newsletters, Part B News - 2016 Issue 9 (September)
Most vitamin B-12 denial rates down while payments nudge up
Subscribe or sign in to view the full article.
Article Overview
This article reviews Medicare claims trends for a vitamin B-12 injection service over two consecutive years, focusing on billing volume, reimbursement changes, and denial-rate movement across high-volume specialties. It is useful for primary care and other outpatient practices, as well as coding and billing professionals who monitor payer behavior, utilization patterns, and claim denial trends.
Why This Topic Matters
It helps readers understand how claim performance for a widely used injectable service changed over time and which specialties were most affected. That can inform benchmarking, revenue-cycle review, and denial management efforts without needing to read the full premium analysis.
What You Will Learn
- How Medicare claims trends changed for a commonly billed injectable service across two years.
- Which specialties were among the highest-volume billers for the service.
- How reimbursement and denial rates varied among the specialties discussed.
- How the article frames the service within broader high-volume claims reporting.
Who Should Read This
- Medical coders
- Billing specialists
- Revenue cycle staff
- Primary care practices
- Internal medicine practices
- Family practice practices
- Specialty practices
- Practice managers
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com